Active Pharmaceutical Ingredient Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Active Pharmaceutical Ingredient (API) Market to 2027 - Global Analysis and Forecasts By Type of Synthesis ( Biotech, Synthetic ); Therapeutic Application (Cardiology, Oncology, CNS and Neurology, Orthopaedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others )

Report Code: TIPRE00003407 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
The pharmaceutical drugs are made up of two core components: the API, which is the vital ingredient and the excipients, are the substances which helps in delivering the API to the human system. The pharmaceuticals companies use certain standards to control and regulate the strength of the API in each drug. However, the standard varies from one brand to another. Many pharmaceutical companies located in the United States and Europe have started outsourcing the API manufacturing in order to reduce the costs on expensive equipment, employees and infrastructure.

MARKET DYNAMICS
The Active Pharmaceutical Ingredient (API) market is anticipated to grow in the forecast period owing to driving factors such as growing prevalence of chronic diseases, advancements in technology for API production, rising adoption of generic medicine, increasing focus on personalize medicine and increasing investments in the pharmaceutical sector. The market is subject to various stringent laws and regulations that deal with patenting, testing, safety, efficacy and marketing and unfavorable drug price control policies across various countries hinders with the market growth.

MARKET SCOPE
The "Global Active Pharmaceutical Ingredient (API) Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of active pharmaceutical ingredient (API) market with detailed market segmentation by type of synthesis, therapeutic application and geography. The global Active Pharmaceutical Ingredient (API) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading active pharmaceutical ingredient (API) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global active pharmaceutical ingredient (API) market is segmented on the basis of type of synthesis and therapeutic application. The active pharmaceutical ingredient (API) market, based on type of synthesis is segmented into Biotech and Synthetic. Based on therapeutic application, the market is segmented as cardiology, oncology, CNS and neurology, orthopaedic, endocrinology, pulmonology, gastroenterology, nephrology, ophthalmology and others.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global active pharmaceutical ingredient (API) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The active pharmaceutical ingredient (API) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting active pharmaceutical ingredient (API) market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the active pharmaceutical ingredient (API) market in these regions.


MARKET PLAYERS

The reports cover key developments in the active pharmaceutical ingredient (API) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from active pharmaceutical ingredient (API) market are anticipated to lucrative growth opportunities in the future with the rising demand for active pharmaceutical ingredient (API) market in the global market. Below mentioned is the list of few companies engaged in the active pharmaceutical ingredient (API) market.

The report also includes the profiles of key active pharmaceutical ingredient (API) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Teva Pharmaceutical Industries Ltd.
• AbbVie, Inc.
• Boehringer Ingelheim International GmbH
• Cipla, Inc.
• Merck & Co., Inc.
• Bristol-Myers Squibb Company
• Albemarle Corporation
• Mylan N.V.
• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Active Pharmaceutical Ingredient (API) Market - By Type of Synthesis
1.3.2 Active Pharmaceutical Ingredient (API) Market - By Therapeutic Application
1.3.3 Active Pharmaceutical Ingredient (API) Market - By Region
1.3.3.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET - GLOBAL MARKET ANALYSIS

6.1. ACTIVE PHARMACEUTICAL INGREDIENT (API) - GLOBAL MARKET OVERVIEW
6.2. ACTIVE PHARMACEUTICAL INGREDIENT (API) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET - REVENUE AND FORECASTS TO 2027 - TYPE OF SYNTHESIS

7.1. OVERVIEW
7.2. TYPE OF SYNTHESIS MARKET FORECASTS AND ANALYSIS
7.3. BIOTECH
7.3.1. Overview
7.3.2. Biotech Market Forecast and Analysis
7.4. SYNTHETIC
7.4.1. Overview
7.4.2. Synthetic Market Forecast and Analysis

8. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC APPLICATION

8.1. OVERVIEW
8.2. THERAPEUTIC APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CARDIOLOGY
8.3.1. Overview
8.3.2. Cardiology Market Forecast and Analysis
8.4. ONCOLOGY
8.4.1. Overview
8.4.2. Oncology Market Forecast and Analysis
8.5. CNS AND NEUROLOGY
8.5.1. Overview
8.5.2. CNS and Neurology Market Forecast and Analysis
8.6. ORTHOPAEDIC
8.6.1. Overview
8.6.2. Orthopaedic Market Forecast and Analysis
8.7. ENDOCRINOLOGY
8.7.1. Overview
8.7.2. Endocrinology Market Forecast and Analysis
8.8. PULMONOLOGY
8.8.1. Overview
8.8.2. Pulmonology Market Forecast and Analysis
8.9. GASTROENTEROLOGY
8.9.1. Overview
8.9.2. Gastroenterology Market Forecast and Analysis
8.10. NEPHROLOGY
8.10.1. Overview
8.10.2. Nephrology Market Forecast and Analysis
8.11. OPHTHALMOLOGY
8.11.1. Overview
8.11.2. Ophthalmology Market Forecast and Analysis
8.12. OTHERS
8.12.1. Overview
8.12.2. Others Market Forecast and Analysis

9. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Active Pharmaceutical Ingredient (API) Market Overview
9.1.2 North America Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis
9.1.3 North America Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Type of Synthesis
9.1.4 North America Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Therapeutic Application
9.1.5 North America Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Countries
9.1.5.1 United States Active Pharmaceutical Ingredient (API) Market
9.1.5.1.1 United States Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.1.5.1.2 United States Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.1.5.2 Canada Active Pharmaceutical Ingredient (API) Market
9.1.5.2.1 Canada Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.1.5.2.2 Canada Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.1.5.3 Mexico Active Pharmaceutical Ingredient (API) Market
9.1.5.3.1 Mexico Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.1.5.3.2 Mexico Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.2. EUROPE
9.2.1 Europe Active Pharmaceutical Ingredient (API) Market Overview
9.2.2 Europe Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis
9.2.3 Europe Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Type of Synthesis
9.2.4 Europe Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Therapeutic Application
9.2.5 Europe Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Active Pharmaceutical Ingredient (API) Market
9.2.5.1.1 Germany Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.2.5.1.2 Germany Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.2.5.2 France Active Pharmaceutical Ingredient (API) Market
9.2.5.2.1 France Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.2.5.2.2 France Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.2.5.3 Italy Active Pharmaceutical Ingredient (API) Market
9.2.5.3.1 Italy Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.2.5.3.2 Italy Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.2.5.4 Spain Active Pharmaceutical Ingredient (API) Market
9.2.5.4.1 Spain Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.2.5.4.2 Spain Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.2.5.5 United Kingdom Active Pharmaceutical Ingredient (API) Market
9.2.5.5.1 United Kingdom Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.2.5.5.2 United Kingdom Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Active Pharmaceutical Ingredient (API) Market Overview
9.3.2 Asia-Pacific Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis
9.3.3 Asia-Pacific Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Type of Synthesis
9.3.4 Asia-Pacific Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Therapeutic Application
9.3.5 Asia-Pacific Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Active Pharmaceutical Ingredient (API) Market
9.3.5.1.1 Australia Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.3.5.1.2 Australia Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.3.5.2 China Active Pharmaceutical Ingredient (API) Market
9.3.5.2.1 China Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.3.5.2.2 China Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.3.5.3 India Active Pharmaceutical Ingredient (API) Market
9.3.5.3.1 India Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.3.5.3.2 India Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.3.5.4 Japan Active Pharmaceutical Ingredient (API) Market
9.3.5.4.1 Japan Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.3.5.4.2 Japan Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.3.5.5 South Korea Active Pharmaceutical Ingredient (API) Market
9.3.5.5.1 South Korea Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.3.5.5.2 South Korea Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Active Pharmaceutical Ingredient (API) Market Overview
9.4.2 Middle East and Africa Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis
9.4.3 Middle East and Africa Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Type of Synthesis
9.4.4 Middle East and Africa Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Therapeutic Application
9.4.5 Middle East and Africa Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Active Pharmaceutical Ingredient (API) Market
9.4.5.1.1 South Africa Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.4.5.1.2 South Africa Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.4.5.2 Saudi Arabia Active Pharmaceutical Ingredient (API) Market
9.4.5.2.1 Saudi Arabia Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.4.5.2.2 Saudi Arabia Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.4.5.3 U.A.E Active Pharmaceutical Ingredient (API) Market
9.4.5.3.1 U.A.E Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.4.5.3.2 U.A.E Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Active Pharmaceutical Ingredient (API) Market Overview
9.5.2 South and Central America Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis
9.5.3 South and Central America Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Type of Synthesis
9.5.4 South and Central America Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Therapeutic Application
9.5.5 South and Central America Active Pharmaceutical Ingredient (API) Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Active Pharmaceutical Ingredient (API) Market
9.5.5.1.1 Brazil Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.5.5.1.2 Brazil Active Pharmaceutical Ingredient (API) Market by Therapeutic Application
9.5.5.2 Argentina Active Pharmaceutical Ingredient (API) Market
9.5.5.2.1 Argentina Active Pharmaceutical Ingredient (API) Market by Type of Synthesis
9.5.5.2.2 Argentina Active Pharmaceutical Ingredient (API) Market by Therapeutic Application

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ACTIVE PHARMACEUTICAL INGREDIENT (API) MARKET, KEY COMPANY PROFILES

11.1. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ABBVIE INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CIPLA INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MERCK
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BRISTOL-MYERS SQUIBB COMPANY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ALBEMARLE CORPORATION
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MYLAN N.V.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. AUROBINDO PHARMA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SUN PHARMACEUTICAL INDUSTRIES LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Teva Pharmaceutical Industries Ltd.
2. AbbVie, Inc.
3. Boehringer Ingelheim International GmbH
4. Cipla, Inc.
5. Merck & Co., Inc.
6. Bristol-Myers Squibb Company
7. Albemarle Corporation
8. Mylan N.V.
9. Aurobindo Pharma
10. Sun Pharmaceutical Industries Ltd.